1079 related articles for article (PubMed ID: 26333104)
21. Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging.
Ahlawat S; Blakeley J; Montgomery E; Subramaniam RM; Belzberg A; Fayad LM
Skeletal Radiol; 2013 Sep; 42(9):1317-22. PubMed ID: 23649401
[TBL] [Abstract][Full Text] [Related]
22. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.
Nishida Y; Ikuta K; Ito S; Urakawa H; Sakai T; Koike H; Ito K; Imagama S
Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792
[TBL] [Abstract][Full Text] [Related]
23. Malignant involvement of the peripheral nervous system in patients with cancer: multimodality imaging and pathologic correlation.
Crush AB; Howe BM; Spinner RJ; Amrami KK; Hunt CH; Johnson GB; Murphy RC; Morreale RF; Peller PJ
Radiographics; 2014; 34(7):1987-2007. PubMed ID: 25384297
[TBL] [Abstract][Full Text] [Related]
24. [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation.
Tsai LL; Drubach L; Fahey F; Irons M; Voss S; Ullrich NJ
J Neurooncol; 2012 Jul; 108(3):469-75. PubMed ID: 22407214
[TBL] [Abstract][Full Text] [Related]
25. Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI.
Matsumine A; Kusuzaki K; Nakamura T; Nakazora S; Niimi R; Matsubara T; Uchida K; Murata T; Kudawara I; Ueda T; Naka N; Araki N; Maeda M; Uchida A
J Cancer Res Clin Oncol; 2009 Jul; 135(7):891-900. PubMed ID: 19101731
[TBL] [Abstract][Full Text] [Related]
26. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas.
Wasa J; Nishida Y; Tsukushi S; Shido Y; Sugiura H; Nakashima H; Ishiguro N
AJR Am J Roentgenol; 2010 Jun; 194(6):1568-74. PubMed ID: 20489098
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1.
Mautner VF; Brenner W; Fünsterer C; Hagel C; Gawad K; Friedrich RE
Anticancer Res; 2007; 27(4A):1819-22. PubMed ID: 17649778
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1.
Salamon J; Derlin T; Bannas P; Busch JD; Herrmann J; Bockhorn M; Hagel C; Friedrich RE; Adam G; Mautner VF
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):685-92. PubMed ID: 23232507
[TBL] [Abstract][Full Text] [Related]
29. Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.
Mautner VF; Asuagbor FA; Dombi E; Fünsterer C; Kluwe L; Wenzel R; Widemann BC; Friedman JM
Neuro Oncol; 2008 Aug; 10(4):593-8. PubMed ID: 18559970
[TBL] [Abstract][Full Text] [Related]
30. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center.
Kim DH; Murovic JA; Tiel RL; Moes G; Kline DG
J Neurosurg; 2005 Feb; 102(2):246-55. PubMed ID: 15739552
[TBL] [Abstract][Full Text] [Related]
31. Plurifocal malignant peripheral nerve sheath tumor demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Bertagna F; Bosio G; Biasiotto G; Savelli G; Rodella C; Giubbini R; Rosenbaum J; Alavi A
Jpn J Radiol; 2009 Oct; 27(8):320-3. PubMed ID: 19856228
[TBL] [Abstract][Full Text] [Related]
32. [Extracerebral neoplastic manifestations in neurofibromatosis 1: integrated diagnostic imaging].
Ferrozzi F; Zuccoli G; Bacchini E; Piazza P; Sigorini M; Virdis R
Radiol Med; 1998 Dec; 96(6):562-9. PubMed ID: 10189917
[TBL] [Abstract][Full Text] [Related]
33. Giant malignant nerve sheath tumor of lumbosacral plexus with intraspinal extension in a child with neurofibromatosis type 1.
Pratap A; Nepal P; Agrawal A; Singh MP; Pandey SR
Pediatr Neurosurg; 2007; 43(5):410-3. PubMed ID: 17786009
[TBL] [Abstract][Full Text] [Related]
34. Value of PET in the assessment of patients with neurofibromatosis type 1.
Bredella MA; Torriani M; Hornicek F; Ouellette HA; Plamer WE; Williams Z; Fischman AJ; Plotkin SR
AJR Am J Roentgenol; 2007 Oct; 189(4):928-35. PubMed ID: 17885067
[TBL] [Abstract][Full Text] [Related]
35. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
[TBL] [Abstract][Full Text] [Related]
36. Malignant peripheral nerve sheath tumors: an update.
Fuchs B; Spinner RJ; Rock MG
J Surg Orthop Adv; 2005; 14(4):168-74. PubMed ID: 16442014
[TBL] [Abstract][Full Text] [Related]
37. Foreign Body Abscess Mimicking a Malignant Peripheral Nerve Sheath Tumor in a Patient With Neurofibromatosis Type 1.
Salamon J; Hagel C; Friedrich RE; Mautner VF; Derlin T
Clin Nucl Med; 2015 Aug; 40(8):674-5. PubMed ID: 26018702
[TBL] [Abstract][Full Text] [Related]
38. Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.
Uthoff J; De Stefano FA; Panzer K; Darbro BW; Sato TS; Khanna R; Quelle DE; Meyerholz DK; Weimer J; Sieren JC
J Neuroradiol; 2019 May; 46(3):179-185. PubMed ID: 29958847
[TBL] [Abstract][Full Text] [Related]
39. [Syndromic abdominal ganglioneuroma: a rare cause of false-positive findings in the F-18 FDG PET / CT in neurofibromatosis type 1].
Derlin T; Hagel C; Mautner VF
Rofo; 2014 Jul; 186(7):706-7. PubMed ID: 24407706
[No Abstract] [Full Text] [Related]
40. Primary malignant peripheral nerve sheath tumor of the lung in a young child without neurofibromatosis type 1.
Muwakkit SA; Rodriguez-Galindo C; El Samra AI; Khoury R; Akel SR; Mroueh S; Razzouk B; Abboud MR
Pediatr Blood Cancer; 2006 Oct; 47(5):636-8. PubMed ID: 16544294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
